Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds
Meeting ReportPhysics, Instrumentation & Data Sciences

Feasibility of 18F-THK5351 PET quantitation using the Centiloid scale

Tensho Yamao, Kenta Miwa, Hiroshi Matsuda, Go Akamatsu, Kei Wagatsuma and Harumasa Takano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1182;
Tensho Yamao
2National Center of Neurology and Psychiatry Kodaira Japan
3National Center of Neurology and Psychiatry Kodaira Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kenta Miwa
1Department of Radiological Sciences International University of Health and Welfare Ohtawara Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroshi Matsuda
2National Center of Neurology and Psychiatry Kodaira Japan
3National Center of Neurology and Psychiatry Kodaira Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Go Akamatsu
4Imaging Physics Team National Institute of Radiological Sciences Chiba Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kei Wagatsuma
5Research Team for Neuroimaging Tokyo Metropolitan Institute of Gerontology Tokyo Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Harumasa Takano
2National Center of Neurology and Psychiatry Kodaira Japan
3National Center of Neurology and Psychiatry Kodaira Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

1182

Objectives: Tau PET imaging has played a key role in assessing tau pathology associated with Alzheimer disease (AD) in vivo. Standard methods of evaluation are important for PET data analysis, but such standards have not been established for tau PET imaging. The Centiloid (CL) scale has recently been proposed as a standard method of quantifying amyloid on PET images. We therefore aimed to determine whether CL values calculated from 18F-THK5351 PET images could serve as a standardized analytical method and identify target regions in direct comparisons of different tracers for tau PET.

Methods: We acquired 18F-THK5351 PET images 40 ± 5 minutes after tracer injection and MR images from 47 patients with normal cognition (NC) (age, 66 ± 8 years) and 28 with probable AD (age, 72 ± 8 years). All MRI data were co-registered and spatially normalized to the Montreal Neurological Institute (MNI)-152 template using PMOD software. All PET data were co-registered to the corresponding MRI data from each patient and spatially normalized into MNI-space by applying transformation parameters calculated from MRI images. The cerebellar cortex volume-of-interest (VOI) was manually designated as a reference region. Between-group comparisons proceeded using two-sample t-tests in Statistical Parametric Mapping version 12 (SPM12) for tau deposit values. The standard cortex (CTX) VOI was designated using t values to minimize the contribution of monoamine oxidase B (MAO-B) that non-specifically accumulates tau. Mean standardized uptake value ratios (SUVR) for tau for all patients were calculated using CTX-VOI and reference VOI. We converted SUVR to CL values.

Results: The parameters for two-sample t-tests comprised p < 0.01 (T = 2.40) and an extent threshold of 200. The retention of 18F-THK5351 was predominant in the angular gyrus, the inferior temporal cortex and parieto-occipital region in the patients with AD. The average SUVR ± standard deviation (SD) of patients with NC and AD were 1.35 ± 0.300 and 1.67 ± 0.180, respectively. The equation used to convert 18F-THK5351 to CL units was: CL = 100 (TauSUVR - 1.35)/0.324. The CL values for patients with NC and AD ranged from -144 to 104 (0.290 ± 54.9) and -111 to 234 (105 ± 90.9), respectively.

Conclusions: Tau PET data with 18F-THK5351 can be expressed using the CL scale, and CL might serve as a standard quantitative method. The difference in 18F-THK5351 retention between NC and AD was larger when CL rather than SUVR was applied to tau PET images. The Centiloid scale can be applied to both amyloid PET and tau PET imaging.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 60, Issue supplement 1
May 1, 2019
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Feasibility of 18F-THK5351 PET quantitation using the Centiloid scale
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Feasibility of 18F-THK5351 PET quantitation using the Centiloid scale
Tensho Yamao, Kenta Miwa, Hiroshi Matsuda, Go Akamatsu, Kei Wagatsuma, Harumasa Takano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1182;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Feasibility of 18F-THK5351 PET quantitation using the Centiloid scale
Tensho Yamao, Kenta Miwa, Hiroshi Matsuda, Go Akamatsu, Kei Wagatsuma, Harumasa Takano
Journal of Nuclear Medicine May 2019, 60 (supplement 1) 1182;
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Physics, Instrumentation & Data Sciences

  • Deep Learning Based 3D Dose Estimation from Prompt Gamma Distribution for Proton Therapy Monitoring
  • Data-driven respiratory signal estimation from finely sampled projection data in conventional cardiac perfusion SPECT imaging.
  • Clinical feasibility of quantitative holmium-166 SPECT in presence of technetium-99m colloid
Show more Physics, Instrumentation & Data Sciences

Data Analysis & Management Posters

  • Evaluation of Quantitative Whole Body Dynamic FDG-PET Using Block Sequence Regularized Expectation Maximization (BSREM) Reconstruction
  • NaF-PET/CT for assessment of temporomandibular joint osseous activity in rheumatoid arthritis patients and healthy subjects
Show more Data Analysis & Management Posters

Similar Articles

SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire